Royal UNIBREW A/S
Share buy-back program
Share buy-back program
COMPANY ANNOUNCEMENT NO 58/2025 - November 24, 2025
On August 26, 2025, Royal Unibrew initiated a share buy-back program, cf. company announcement no. 44/2025.
The program is carried out under Art. 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of April 16, 2014, on market abuse, as amended (the Market Abuse Regulation - MAR) and the Commission Delegated Regulation (EU) No 2016/1052 of March 8, 2016.
The share buy-back program is expected to be realized in the period from August 27, 2025, to December 19, 2025. The total transaction value of the share buy-backs in the period will not exceed DKK 300m.
The following transactions on Nasdaq Copenhagen A/S have been made under the program:
| Number of Shares | Average purchase price DKK | Transaction value, DKK | |
| Accumulated, last announcement | 472,500 | 488.68 | 230,901,565 |
| November 17, 2025 | 3,000 | 538.44 | 1,615,320 |
| November 18, 2025 | 4,000 | 533.81 | 2,135,240 |
| November 19, 2025 | 4,500 | 529.66 | 2,383,470 |
| November 20, 2025 | 4,000 | 526.08 | 2,104,320 |
| November 21, 2025 | 3,000 | 541.73 | 1,625,190 |
| Total accumulated under the program | 491,000 | 490.36 | 240,765,105 |
With the transactions stated above Royal Unibrew owns a total of 1,094,042 shares, corresponding to 2.2% of the share capital. The total amount of shares in the company is 50,200,000, including treasury shares.
For further information please contact:
Flemming Ole Nielsen (Head of Investor Relations)
E-mail: Flemming.Nielsen@royalunibrew.com
Telephone: +45 25 41 68 04
Encl.
Attachments
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Enlivex Therapeutics Ltd24.11.2025 13:55:00 CET | Press release
Enlivex Announces $212,000,000 Private Placement to Initiate World’s First Prediction Markets Digital Asset Treasury Strategy, via RAIN token Accumulation, and the Appointment of Matteo Renzi, Former Prime Minister of Italy, to its Board
Ress Life Investments A/S24.11.2025 13:46:30 CET | Press release
Ress Life Investments A/S announces capital decrease
Biogen Inc.24.11.2025 13:30:00 CET | Press release
Biogen and Dayra Therapeutics Announce Research Collaboration to Discover and Develop Oral Macrocyclic Peptides for a Range of Immunological Conditions
GetYourGuide24.11.2025 13:00:00 CET | Press release
GetYourGuide Unveils 2026 Hidden Trends List: Birdwatching, Coffee Culture and Skill-Seeking Set to Drive Experience-Led Trips
Genmab A/S24.11.2025 13:00:00 CET | Press release
Genmab to Participate in a Fireside Chat at the Citi Global Healthcare Conference in Miami
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom